Generate a tailored SOP for Dr. Ronald Breaker. Improve your application with a focused, well-structured draft.
Ronald Breaker is a Sterling Professor at Yale University in the Department of Molecular, Cellular, and Developmental Biology, jointly appointed in the Department of Molecular Biophysics and Biochemistry. As an Investigator at the Howard Hughes Medical Institute, he focuses on the synthesis and catalytic properties of nucleic acids. Dr. Breaker completed his graduate studies at Purdue University and conducted postdoctoral research at the Scripps Research Institute, where he pioneered in vitro evolution strategies to isolate novel RNA enzymes, termed ribozymes, and catalytic DNAs known as deoxyribozymes. Since establishing his laboratory at Yale in 1995, he has expanded research to include molecular switch technologies and next-generation biosensors, along with discoveries of metabolites that regulate messenger RNA elements called riboswitches. He has published over 220 scientific papers, received numerous awards including the Arthur Greer Memorial Prize, and is a member of the U.S. National Academy of Sciences. Dr. Breaker also cofounded biotechnology companies and serves on editorial boards for leading scientific journals.
Yale University • New Haven, CT
Lead a research laboratory focusing on nucleic acids, including ribozymes and deoxyribozymes.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.